TY  - GEN
AU  - Sánchez-Juan, Pascual
AU  - Valeriano-Lorenzo, Elizabeth
AU  - Ruiz-González, Alicia
AU  - Pastor, Ana Belén
AU  - Rodrigo Lara, Hector
AU  - López-González, Francisco
AU  - Zea-Sevilla, María Ascensión
AU  - Valentí, Meritxell
AU  - Frades, Belén
AU  - Ruiz, Paloma
AU  - Saiz, Laura
AU  - Burgueño-García, Iván
AU  - Calero, Miguel
AU  - Del Ser, Teodoro
AU  - Rábano, Alberto
PY  - 2024
DO  - 10.1093/brain/awae035
UR  - http://hdl.handle.net/20.500.12105/19904
AB  - Glial fibrillary acidic protein (GFAP), a proxy of astrocyte reactivity, has been proposed as biomarker of Alzheimer's disease. However, there is limited information about the correlation between blood biomarkers and post-mortem neuropathology. In a...
LA  - eng
PB  - Oxford University Press
KW  - Astrocyte
KW  - Alzheimer’s disease
KW  - Blood biomarkers
KW  - Neuropathology
KW  - tau
KW  - Glial Fibrillary Acidic Protein
KW  - Astrocytes
KW  - Neurofibrillary Tangles
KW  - Atrophy
KW  - Alzheimer Disease
KW  - Brain
KW  - Biomarkers
KW  - Humans
KW  - Female
KW  - Male
KW  - Aged
TI  - Serum GFAP levels correlate with astrocyte reactivity, post-mortem brain atrophy and neurofibrillary tangles
TY  - research article
ER  -